0001209191-22-027668.txt : 20220506
0001209191-22-027668.hdr.sgml : 20220506
20220506174306
ACCESSION NUMBER: 0001209191-22-027668
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220505
FILED AS OF DATE: 20220506
DATE AS OF CHANGE: 20220506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIEGALL CLAY B
CENTRAL INDEX KEY: 0001167496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39398
FILM NUMBER: 22902593
MAIL ADDRESS:
STREET 1: 21823 30TH DR SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nurix Therapeutics, Inc.
CENTRAL INDEX KEY: 0001549595
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270838048
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1130
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 205
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: (415) 660-5320
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 205
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: Nurix, Inc.
DATE OF NAME CHANGE: 20120509
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-05
0
0001549595
Nurix Therapeutics, Inc.
NRIX
0001167496
SIEGALL CLAY B
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO
CA
94158
1
0
0
0
Director Stock Option (right to buy)
10.39
2022-05-05
4
A
0
17500
0.00
A
2032-05-04
Common Stock
17500
17500
D
The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 5, 2023, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
/s/ Christine Ring, as Attorney-in-Fact for Clay B. Siegall
2022-05-06